Now Reading: India’s pharma exports rise 6.8% to $8.1bn in Q1
-
01
India’s pharma exports rise 6.8% to $8.1bn in Q1
India’s pharmaceutical exports grew 6.8% year-on-year to $8.1 billion in the first quarter ended June, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) said. Drug formulations and biologicals, the largest category, rose…
The Story in Brief
India’s pharmaceutical exports grew 6.8% year-on-year to $8.1 billion in the first quarter ended June, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) said. Drug formulations and biologicals, the largest category, rose 4.14% to $5.98 billion, making up 73.85% of total exports.
Bulk drugs and drug intermediates grew 13.84% to $1.36 billion, vaccine exports jumped 35.68% to $0.39 billion, and surgical products rose 11.95% to $0.21 billion. The US remained the top destination with $2.50 billion exports (30.89% share), followed by Brazil, the UK, the Netherlands and France. The top 25 destinations accounted for 70% of exports.
The Indian Opinion
The usual narrative that Indian pharma exports are over-dependent on US generics overlooks double-digit growth in Europe, Africa, Latin America and ASEAN. Pharmexcil data shows nearly 70% of shipments now go beyond the top 25 destinations. The real test will be whether Indian companies can maintain regulatory compliance and quality across diverse new markets as volumes grow.
Source: thehindu.com
This story was synthesised by AI from the source linked above.
